We launched Atara Biotherapeutics in August 2012 to help patients with serious diseases and few therapeutic options. We're named after Atara Ciechanover who suffered from cancer before passing away. We are considered a leading off-the-shelf T-cell immunotherapy company (Nasdaq ATRA) developing novel treatments for patients with cancer, autoimmune and viral diseases.
Atara Bio seeks a dedicated Sr. Medical Science Liaison (MSL) to join a newly formed field team in our growing Medical Affairs organization. MSLs have the opportunity to work with a new cellular based therapeutic platform providing scientific education to healthcare providers in the transplant space. Initial responsibilities include clinical trial site support and scientific exchange with key opinion leaders and relevant health care providers on Atara related products. Later stage work includes pre-launch and launch related activities for lead product line in anticipation for full commercialization.
Reports to Senior Director, North American MSLs
Location Field-based, variable; Northeast preferred
Establishes and maintains relationships with target health care professionals:
Scientific exchange with National and Regional thought leaders.
Builds relationships with key HCP and Scientists.
Participates and represents Atara at various scientific/cooperative group meetings.
Participates in the identification and completion of clinical trials:
Participates in the education of healthcare professionals and Atara employees:
Participates in the training of healthcare professionals in the use of Atara product(s).
Pending commercialization, serves as a resource in the education of sales, marketing and other internal functions.
Participates in the identification and publication of scientific materials.
Travel Travel required (up to 75%)
Subject to extended periods of sitting and/or standing, and vision to monitor. Work is generally performed in an office or clinical environment. Car and airplane travel is an essential part of the role.
Education: Advanced degree (MD, Pharm D, or PhD) required
Experience and Skills:
Required: minimum 2 years of experience as a field MSL.
Demonstrative therapeutic experience/research or substantive patient care experience is required.
Medical, clinical or research experience in transplant/oncology is preferred.
Ability to demonstrate expertise of key skills, capabilities and competencies.
Role model for Atara's Values of patients first, innovation teamwork, community and mindset.
More About Atara Bio
Now in our sixth year, we're proud of our team of 260+ Atarians co-located by design in South San Francisco (corporate headquarters) and Southern California (R&D and manufacturing headquarters in the northwest Los Angeles area) with a newly-established European headquarters in Zug, Switzerland. Atara also has a R&D site in the Denver, Colorado area and an office in New York City. Our Southern California hub is anchored by a new 90,000 sq. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California.
One mission "Transform the lives of patients with serious medical conditions through pioneering science, teamwork and expertise" and a singular vision "Cell therapy treatment for every patient, any time provide inspiration and direction for all of us."
The Company's off-the-shelf, allogeneic T-cells are bioengineered from donors with healthy immune function and allow for rapid delivery from inventory to patients without a requirement for pretreatment. Atara's T-cell immunotherapies are designed to precisely recognize and eliminate cancerous or diseased cells without affecting normal, healthy cells.
Atara's most advanced T-cell immunotherapy in development, tabelecleucel, or tab-cel (formerly known as ATA129), is being developed for the treatment of patients with Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+ PTLD) who have failed rituximab, as well as other EBV-associated hematologic and solid tumors, including nasopharyngeal carcinoma (NPC). Tab-cel is in Phase 3 clinical development for the treatment of EBV+ PTLD following an allogeneic hematopoietic cell transplant (MATCH study) or solid organ transplant (ALLELE study).
Atara is also developing off-the-shelf, allogeneic ATA188 and autologous ATA190 T-cell immunotherapies using a complementary targeted antigen recognition technology for specific EBV antigens believed to be important for the potential treatment of multiple sclerosis (MS). A Phase 1 clinical study of autologous ATA190 in patients with progressive MS is ongoing. Atara is also advancing a Phase 1 clinical study of ATA188 in patients with progressive or relapsing-remitting MS across clinical sites in the United States and Australia. Atara's clinical pipeline also includes ATA520 targeting Wilms Tumor 1 (WT1) and ATA230 directed against cytomegalovirus (CMV).
Working at Atara Bio
People at Atara Bio are high integrity, roll-up-your-sleeves, get-it-done types who are keenly committed to putting patients first, advancing medical care and doing so with demonstrated urgency. At their core Atarians are people who work well with others and are "team-centric", have purposeful curiosity and can't wait to save patient lives. And similar to other biotech companies who have so many accomplished people, we expect humility (we are a "low hubris" sort of place), flexibility, respect, teamwork, good judgment and getting the most out of any dollar we spend. We also expect to enjoy the journey (and each other) as we move forward with a shared responsibility to teach and to learn from what we do and from our teammates.
Atara Bio is an equal opportunity employer and makes employment decisions on the basis of merit and other lawful factors. In accordance with applicable law, the Company prohibits discrimination based on race, color, religion, creed, sex, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity, expression or dysphoria, marital status, age, national origin or ancestry, physical or mental disability, medical condition, genetic information, veteran status, caregiver status, sexual orientation, transgender status or any other classification protected by federal, state or local laws or because of the individual's association with a member of a protected group or connection to an organization or group related to a protected group.
We comply with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Atara Bio in the United States.